Whole Blood mRNA Expression Profiling of Crohn's Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes

被引:0
|
作者
Li, Katherine
Brodmerkel, Carrie
Telesco, Shannon
Ma, Keying
Gasink, Christopher
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S179 / S179
页数:1
相关论文
共 50 条
  • [1] Assessment of Sleep Impairment in Patients With Crohn's Disease: Results From the Ustekinumab Certifi Study
    Gasink, Christopher
    Chan, Daphne
    Gao, Long-Long
    Schenkel, Brad
    Han, Chenglong
    GASTROENTEROLOGY, 2013, 144 (05) : S231 - S231
  • [2] Clinical utility of ustekinumab in Crohn's disease
    Kotze, Paulo Gustavo
    Ma, Christopher
    Almutairdi, Abdulelah
    Panaccione, Remo
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 35 - 47
  • [3] The Gut Microbiome Differentiates Clinical Phenotypes in Moderate to Severe Crohn's Disease: Results From the CERTIFI Study
    Ding, Tao
    Telesco, Shannon
    Monast, Calixte S.
    Brodmerkel, Carrie
    Yatsunenko, Tanya
    Das, Anuk
    Schloss, Patrick
    GASTROENTEROLOGY, 2015, 148 (04) : S713 - S713
  • [4] Clinical experience with ustekinumab in selected Crohn's disease patients
    Saman, S.
    Klag, T.
    Wendler, J.
    Goetz, M.
    Malek, N. P.
    Wehkamp, J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S352 - S353
  • [5] Ustekinumab in Crohn's disease: effectiveness and safety in clinical practice
    Saldana Duenas, Cristina
    Rullan Iriarte, Maria
    Elosua Gonzalez, Alfonso
    Rodriguez Gutierrez, Cristina
    Rubio Iturria, Saioa
    Nantes Castillejo, Oscar
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (09): : 497 - 505
  • [6] Positioning Ustekinumab in Crohn's Disease: From Clinical Evidence to Clinical Practice
    Danese, Silvio
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10): : 1258 - 1266
  • [7] CLINICAL, SEROLOGIC, AND GENOMIC PREDICTORS OF RESPONSE TO USTEKINUMAB IN CROHN'S DISEASE
    Du, Lillian
    Li, Dalin
    Syal, Gaurav
    Bonthala, Nirupama
    Melmed, Gil
    Targan, Stephan R.
    Vasiliauskas, Eric
    Ziring, David
    Haritunians, Talin
    Botwin, Gregory J.
    Hwang, Linda
    Yang, Shaohong
    Rabizadeh, Shervin
    Ha, Christina
    McGovern, Dermot P. B.
    GASTROENTEROLOGY, 2020, 158 (06) : S952 - S953
  • [8] EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR CROHN'S DISEASE IN ROUTINE CLINICAL PRACTICE
    Lynn, Amanda M.
    Barsky, Maria
    Ahmed, Waseem
    Zullow, Samantha
    Jairath, Vipul
    Kochhar, Gursimran
    Weiss, Aaron
    Phipps, Meaghan
    Agrawal, Mansi
    Click, Benjamin H.
    Meserve, Joseph
    Swaminath, Arun
    Bohm, Matthew
    Sagi, Sashidhar
    Fischer, Monika
    Hudesman, David
    Chang, Shannon
    Lawlor, Garrett
    Lukin, Dana J.
    Ullman, Thomas A.
    Boland, Brigid S.
    Singh, Siddharth
    Sandborn, William J.
    Regueiro, Miguel D.
    Shen, Bo
    Kane, Sunanda V.
    Loftus, Edward V.
    Dulai, Parambir S.
    GASTROENTEROLOGY, 2019, 156 (06) : S885 - S885
  • [9] Oral Microbiota Associated with Clinical Efficacy of Ustekinumab in Crohn's Disease
    Xu, Feiyang
    Xie, Rui
    He, Le
    Wang, Honggang
    Zhu, Yifan
    Yang, Xiaozhong
    Yu, Huiming
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2025,
  • [10] Ustekinumab achieves good clinical Results for perianal Crohn's Disease
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 104 - 104